Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment
RotaChrom TechnologiesFebruary 8, 2021 GMT
New Partnership Aims to Develop More Efficient, Cost-Effective Process to Purify Remdesivir
Budapest, Hungary, Feb. 08, 2021 (GLOBE NEWSWIRE) via NewMediaWire RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab″), a cyclodextrin research, development and manufacturing company. This strategic partnership between Cyclolab and RotaChrom aims to develop a more efficient and cost-effective process to purify Remdesivir, which is a widely used treatment option for COVID-19.
global cyclodextrin market is projected to grow at a CAGR of 6.3% during the forecast period 2020-2026
tanmayFebruary 5, 2021
Global Cyclodextrin Market Overview 2020-2026
Cyclodextrins (CDs) are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by -1,4 glycosidic bonds. CDs are mainly used for the improvement of water-solubility and bioavailability of medicinal products. Cyclodextrins form a toroid (truncated cone) configuration with multiple hydroxyl groups at each end.
This allows them to encapsulate hydrophobic compounds without losing their solubility in water. According to Gen Consulting Company, global cyclodextrin market is projected to grow at a CAGR of 6.3% during the forecast period 2020-2026. Growing potential for cyclodextrin in agriculture industry is the chief contributor for the growth of the market.